Yttrium-90 (90Y) in the principal radionuclide therapies: An efficacy correlation between peptide receptor radionuclide therapy, radioimmunotherapy and transarterial radioembolization therapy. Ten years of experience (1999

Yttrium-90 (90Y) in the principal radionuclide therapies: An efficacy correlation between peptide receptor radionuclide therapy, radioimmunotherapy and transarterial radioembolization therapy. Ten years of experience (1999–2009)

Published:2011-12 Issue:3 Volume:80 Page:393-410
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Goffredo Veronica,Paradiso Angelo,Ranieri Girolamo,Gadaleta Cosmo Damiano

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference177 articles.

1. Application of radiometallic compounds for medical diagnosis and therapy;Saji;Yakugaku Zasshi,2008

2. Radiofrequency ablation of 40 lung neoplasms: preliminary results;Gadaleta;AJR Am J Roentgenol,2004

3. Radiofrequency thermal ablation of 69 lung neoplasms;Gadaleta;J Chemother,2004

4. Radiofrequency thermal ablation in the treatment of lung malignancies;Gadaleta;In Vivo,2006

5. Hypoxic stop-flow perfusion with mitomycin-C in the treatment of multifocal liver metastases. Usefulness of a vascular arterial stent to prevent iatrogenic lesions of the hepatic arterial wall;Gadaleta;J Exp Clin Cancer Res,2003

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updating 90Y Voxel S-Values including internal Bremsstrahlung: Monte Carlo study and development of an analytical model;Physica Medica;2023-08

2. Immunotherapy and the Combination with Targeted Therapies for Advanced Hepatocellular Carcinoma;Cancers;2023-01-20

3. Targeted Therapy for Hepatocellular Carcinoma: Old and New Opportunities;Cancers;2022-08-20

4. The Chemical Scaffold of Theranostic Radiopharmaceuticals: Radionuclide, Bifunctional Chelator, and Pharmacokinetics Modifying Linker;Molecules;2022-05-10

5. Labeling of Hinokitiol with 90Y for Potential Radionuclide Therapy of Hepatocellular Carcinoma;Processes;2021-05-26